Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05986825

Acronym

QUALIVER

Enrollment

Registered

2023-08-14

Start date

2023-08-29

Completion date

2023-12-22

Last updated

2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis Suppurativa

Brief summary

Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.

Interventions

OTHERVerneuil questionnaire Validation

Request patient to Complete the questionnaire for validation of the French version

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥18 years * Patient with Verneuil disease * Beneficiary of or affiliated to a social security insurance * Participation agreement

Exclusion criteria

* Patients physically or mentally unable to complete questionnaires. * Refusal to participate * Patient under legal protection (guardianship, curatorship) or deprived of liberty

Design outcomes

Primary

Measure	Time frame
Validation of the questionnaire	During the visit and 1 week later

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026